Neuro-Oncology Reviews
Volume
27 Number 28
10 October 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 28, 10 October
Lang F, Yang C.
Targeting cell cycle
checkpoints for glioma therapy.
Pharmacol
Ther. 2025 Oct 1;275:108932. doi:
10.1016/j.pharmthera.2025.108932. PMID:
41043693. Review˰
ˍ
Sharma A, Boyce Kennedy L, Van Swearingen AED, Ahluwalia MS,
Bagley SJ, Chiang VL, Chung C, Cittelly DM, Daras M, Davies MA,
Fecci PE, Haas-Kogan DA, Hattangadi-Gluth JA, Jerzak KJ, Kim MM,
Malani R, Mehta MP, Moss NS, Neman J, Nguyen DX, Priceman SJ,
Sahebjam S, Shih HA, Soffietti R, Wang N, Zimmer A, Goldberg S,
Khasraw M, Anders CK, Lin NU; SNO/ASCO Brain Metastasis
Collaborative Think Tanks.
Intracranial
metastases from solid tumors: Call to Action and Consensus from
the Society for Neuro-Oncology and American Society of Clinical
Oncology Collaborative.
Neuro
Oncol. 2025 Oct 1:noaf226. doi:
10.1093/neuonc/noaf226. PMID:
41051254. Guidelines. ˍ
Yan S, Zhu X, Xiao Y.
CD70-targeted
CAR-T/NK therapy: Rationale, advances, and future directions.
Transl
Oncol. 2025 Oct 2;62:102555. doi:
10.1016/j.tranon.2025.102555. PMID:
41043320. Review.
ˍ
Bunse L, Bunse T, Kilian M, Quintana FJ, Platten M.
The
immunology of brain tumors.
Sci
Immunol. 2025 Oct 3;10(112):eads0449. doi:
10.1126/sciimmunol.ads0449. PMID:
41042911. Review.
ˍ
Mahdi J, Trivedi V, Monje M.
The
promise of immunotherapy for central nervous system tumours.
Nat
Rev Immunol. 2025 Oct 6. doi:
10.1038/s41577-025-01227-5. PMID:
41053233. Review˰
ˍ
Chen L, Shu K, Zhang Z, Zhao J.
A
scientometric analysis of global research on gut microbiota and
glioma.
Front
Oncol. 2025 Oct 7;15:1646187. doi:
10.3389/fonc.2025.1646187. PMID:
41127017. Bibliometric analysis. ˍ
Guo S, Fan X, Li W, Bao J, Ma E, Jin H.
Correlation
between allergy and cancer: a systematic review and meta-analysis.
Sci
Rep. 2025 Oct 7;15(1):34901. doi:
10.1038/s41598-025-18646-y. PMID:
41057446. Meta-analysis. ˍ
Li J, Shao T, Kou J, Ni L.
Male-origin
microchimerism and risk of cancer: a systematic review and
meta-analysis.
BMC
Cancer. 2025 Oct 7;25(1):1528. doi:
10.1186/s12885-025-14860-z. PMID:
41057800. Review; Meta-analysis. ˍ
Oztek MA, Wright JN.
Central Nervous
System Embryonal Tumors.
Neuroimaging
Clin N Am. 2025 Oct 7;36(1):85-106. doi:
10.1016/j.nic.2025.08.007. PMID:
41274772. Review˰
ˍ
Powers AM, Neuberger I.
Pediatric
Diffuse Low-Grade Gliomas: Radiology, Symptoms, Treatment, and
Molecular Pathways.
Neuroimaging
Clin N Am. 2025 Oct 7;36(1):23-34. doi:
10.1016/j.nic.2025.08.006. PMID:
41274768. Review˰
ˍ
Singh S, Mohapatra I, Barik D, Zheng H, Kim S, Sharma M, Chen CC,
Singh G.
Harnessing ferroptosis to
transform glioblastoma therapy and surmount treatment resistance.
Cell
Death Discov. 2025 Oct 7;11(1):448. doi:
10.1038/s41420-025-02744-x. PMID:
41057317. Review.
ˍ
Li J, Ross JL, Hambardzumyan D, Brat DJ.
Immunopathology
of Glioblastoma.
Annu
Rev Pathol. 2025 Oct 8. doi:
10.1146/annurev-pathmechdis-042524-025950. PMID:
41061166. Review˰
ˍ
Saltarelli G, Di Cerbo G, Innocenzi A, De Felici C, Splendiani A,
Di Cesare E.
Quantitative MRI in
Neuroimaging: A Review of Techniques, Biomarkers, and Emerging
Clinical Applications.
Brain
Sci. 2025 Oct 8;15(10):1088. doi:
10.3390/brainsci15101088. PMID:
41154182. Review. ˍ
Xu L, Chen S, Fu Y, Zhou T, Yu J, Li J, Chen W.
Neuro-immune-tumor axis in gliomas: a
review of mechanisms, models, and translational opportunities.
Front
Immunol. 2025 Oct 8;16:1682322. doi:
10.3389/fimmu.2025.1682322. PMID:
41132643. Review. ˍ